Completed PHASE3 INTERVENTIONAL NCT00000579

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Lung Diseases Respiratory Distress Syndrome, Adult

Interventions Fluid Management Ketoconazole Low Tidal Volume Ventilation Lysofylline Methylprednisolone Positive End-Expiratory Pressure Pulmonary Artery Catheter

Updated 5 times since 2017 Last updated: Mar 22, 2016 Started: Sep 30, 1994 Completion: Jul 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Lung Diseases and Respiratory Distress Syndrome, Adult and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 5 recorded versions since 1994 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)

Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Baltimore, United States , Boston, United States , Charlottesville, United States , Chicago, United States , Cleveland, United States , Denver, United States , Durham, United States , Houston, United States , Nashville, United States and 11 more locations